# Quadrivalent Influenza VLP Vaccine Dose Ranging Study in Young Adults

> **NCT02307851** · PHASE2 · COMPLETED · sponsor: **Novavax** · enrollment: 400 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** Quadrivalent VLP Vaccine
- **BIOLOGICAL:** Comparator TIV

## Key facts

- **NCT ID:** NCT02307851
- **Lead sponsor:** Novavax
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-11
- **Primary completion:** 2015-06
- **Final completion:** 2015-06
- **Target enrollment:** 400 (ACTUAL)
- **Last updated:** 2016-09-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02307851

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02307851, "Quadrivalent Influenza VLP Vaccine Dose Ranging Study in Young Adults". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02307851. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*